Analog Devices enters its May 20 earnings call with the Street in an unusually bullish mood — and the stock already up 20% in a month.
The analyst activity this week tells the clearest story. Three firms raised price targets in the past two days alone. Wells Fargo lifted its Overweight target from $410 to $470. Cantor Fitzgerald pushed from $400 to $510 while maintaining Overweight. Oppenheimer moved from $400 to $450 on an Outperform. All three held their ratings — this is conviction being repriced upward, not a fresh change of heart. The consensus mean target now runs at $404.65, which is actually a few percent below the current $419.65 close. That gap reflects how quickly the stock has re-rated relative to where analysts had set their marks — the upgrades are still catching up to price. The RSI14 has climbed to just under 70, technically overbought territory, adding a note of near-term caution to an otherwise bullish picture.
The broader fundamental case is not hard to see. Gross margins came in at 64.7% last quarter, with an EBITDA margin of 48.6% — both figures that reflect ADI's high-value analog mix rather than commodity silicon. Revenue grew 30% year-on-year. The bull case centres on secular growth in industrial and communications, plus AI-driven power management demand in data centres. Bears point to softness in automotive and consumer end markets, where revenue has been flat to declining, and flag tariff exposure given ADI's global manufacturing footprint. The P/E of roughly 34.7x on a trailing basis (using the snapshot's trailing multiple, not the optically distorted single-quarter figure) has expanded about five points over the past month as the stock rallied, so investors are paying up for recovery expectations.
Short positioning is modest and provides little friction in either direction. Short interest is 2.1% of the free float — enough to track, but nowhere near a level that materially affects the trading setup. It edged up about 4% on the week. Borrowing remains almost frictionless, with costs at 0.41% APR and availability very loose — well above any threshold that would suggest squeeze dynamics. The ORTEX short score of 32 is relatively benign in the full universe context, and utilization has been easing over the past week, dropping from around 0.6% to 0.38%. Whatever directional tension exists into next week's print, it is not being expressed through the short book.
Options sentiment reinforces the picture of a market leaning constructive but not aggressively so. The put/call ratio is 0.84 — slightly below its 20-day average of 0.87, and sitting 1.2 standard deviations below that mean. Call interest is modestly dominant heading into the event. That is a softer bullish tilt rather than a strong directional bet. The 52-week PCR range runs from 0.62 to 0.99, and the current reading is comfortably in the middle of that band. CEO Vincent Roche sold $3.98 million of stock on May 1, part of a recurring monthly disposal programme. Insider net activity over 90 days is positive on a share-count basis (about 101,000 net), primarily reflecting equity award grants rather than open-market buying. The selling cadence looks programmatic rather than tactical.
Closest peers had a softer day. TXN fell 0.9% and MCHP dropped 1.3%, while MPWR gave back 3.7%. ADI's 3.7% gain on the week stands out against that peer group, meaning it has outpaced most of its analog and mixed-signal comparables heading into the print. The May 20 call is now the focal point: whether the industrial demand recovery is broad-based or narrowly concentrated in AI-adjacent applications is the question that will determine whether the fresh Street targets have room to stick.
See the live data behind this article on ORTEX.
Open ADI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
